Main Menu
Menu

Fact Checks

Publish Date
BlogFact Checks
Fact Check: The NO FAKES Act Won’t Stifle Innovation — It Will Protect It

The rapid advancement of artificial intelligence has given creators and inventors new technological tools to enhance their work — but it has...

BlogFact Checks
Fact Check: Debunking The Myth of “Evergreening” and “Patent Thicketing”

Former Federal Trade Commission Chair Lina Khan recently appeared on The Weekly Show with Jon Stewart, where their discussion revived familiar tropes...

BlogFact Checks
Fact Check: What Critics Get Wrong About the Patent Eligibility Restoration Act

A coalition of anti-patent groups — including the R Street Institute, the Electronic Frontier Foundation, Public Knowledge, and others — recently sent...

BlogFact Checks
Fact Check: Weakening the patent system won’t lower prices for patients. It would undermine medical progress.

In a recent STAT article, I-MAK CEO Tahir Amin argues that abuses of the patent system are leading to higher drug costs....

BlogFact Checks
Fact Check: The Data Doesn’t Support the Existence of So-Called Patent “Thickets”

Several academic authors recently published an article in Health Affairs Forefront advising policymakers in Congress and at the USPTO on the best...

BlogFact Checks
Fact Check: The Myth of So-Called “Royalty Free” and “Open” Standards

The word “open” has become increasingly misused in the world of technology standards. In policy and antitrust terms, an open standard is...

Fact ChecksResources
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology

The Patent Eligibility Restoration Act of 2025 (PERA), sponsored by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE), is bipartisan legislation that...

Fact ChecksResources
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences

The Patent Eligibility Restoration Act of 2025 (PERA), sponsored by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE), is bipartisan legislation that...

BlogFact Checks
Fact Check: Separating Fact From Fiction in Recent FTC/DOJ Listening Sessions on Patents in the Drug Industry

Myths about how patent rights affect competition within the drug industry remain a pressing issue for innovators. Although strong patents play a...

BlogFact Checks
Fact Check: IP Protections Power the U.S. Innovation Economy. MFN Would Undermine this System.

In recent months, federal policymakers have renewed calls for “Most-Favored-Nation” (MFN) drug pricing, which would tie the price of medicines in the...

BlogFact Checks
Fact Check: Setting the Record Straight on Standard-Essential Patents and Innovation

Earlier this year, a coalition of technology industry lobbyists sent a letter to President Trump urging his administration to weaken protections for...

BlogFact Checks
Fact Check: PERA and the PREVAIL Act Would Bolster, Not Harm, Inventors

A bipartisan group of legislators led by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE) recently reintroduced two critical bills to Congress:...

Blog:

Blog, Fact Checks:

Fact Check: Price Controls Would Not Make Diabetes Treatments More Accessible,

05/24/2024
Blog:

Blog, Fact Checks:

Fact Check: The Patent Eligibility Restoration Act Would Not Make Certain Inventions Automatically Patentable,

04/25/2024
Blog:

Blog, Fact Checks:

Fact Check: The WHO Draft Treaty Would Sabotage Pandemic Preparedness,

03/26/2024
Blog:

Blog, Fact Checks:

Fact Check: The Patent Eligibility Restoration Act Would Promote Medical Innovation,

02/14/2024
Blog:

Blog, Fact Checks:

Misusing the Bayh-Dole Act’s March-In Rights is Not an Effective Way to Reduce Drug Prices,

01/29/2024
Blog:

Blog, Fact Checks:

Fact Check: The PREVAIL Act Would Not Protect “Bad” Patents,

12/20/2023
Blog:

Blog, Fact Checks:

The SHOP SAFE Act Would Benefit Consumers and Small Businesses,

11/27/2023
Blog:

Blog, Fact Checks:

Fact Check: PTAB Reform Would Benefit, Not Harm, Small Inventors,

10/20/2023
Blog:

Blog, Fact Checks:

Fact Check: “Reasonable Pricing” Policies Do Not Promote Innovation,

09/22/2023
Blog:

Blog, Fact Checks:

Fact Check: The Patent Eligibility Restoration Act Does Not Allow Patenting of Naturally-Occurring Genes,

08/23/2023
Blog:

Blog, Fact Checks:

Fact Check: The ITC’s Import Process and Bans Help Protect U.S. Innovators,

07/10/2023
Blog:

Blog, Fact Checks:

The Bayh-Dole Act Does Not Impede Knowledge Sharing,

06/16/2023
Scroll to Top